Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115198) titled 'Real-world effectiveness and safety of upadacitinib in difficult-to-treat... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115202) titled 'Application and Safety Evaluation of Saline-Coupled Bipolar Radiofrequenc... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115206) titled 'The Impact of Proactive Nursing on Quality of Life in Thyroid Cancer Pati... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115210) titled 'Motion Correction in Intravascular Ultrasound Sequences Based on Deep Lea... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115214) titled 'Construction of a prospective cohort database for genetic thrombosis gene... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115218) titled 'A phase II clinical study evaluating the efficacy and safety of Decitabin... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115111) titled 'Exploration of the ED50 value and appropriate administration time of alfe... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115114) titled 'Clinical Study of Selinoxor-Based Chemotherapy with Minimal or No Cytotox... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115117) titled 'Study on the Clinical Effect of the "Shoushu Feichang Zhun" Mobile Applic... Read More
Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115120) titled 'Prospective, Open-Label, Single-Center Clinical Study of Iparomlimab and ... Read More